• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类帕金森病基因LRRK2的直系同源基因在不同物种中的功能:对临床前研究中疾病建模的启示

The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.

作者信息

Langston Rebekah G, Rudenko Iakov N, Cookson Mark R

机构信息

Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD 20892, U.S.A.

出版信息

Biochem J. 2016 Feb 1;473(3):221-32. doi: 10.1042/BJ20150985.

DOI:10.1042/BJ20150985
PMID:26811536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5165698/
Abstract

In the period since LRRK2 (leucine-rich repeat kinase 2) was identified as a causal gene for late-onset autosomal dominant parkinsonism, a great deal of work has been aimed at understanding whether the LRRK2 protein might be a druggable target for Parkinson's disease (PD). As part of this effort, animal models have been developed to explore both the normal and the pathophysiological roles of LRRK2. However, LRRK2 is part of a wider family of proteins whose functions in different organisms remain poorly understood. In this review, we compare the information available on biochemical properties of LRRK2 homologues and orthologues from different species from invertebrates (e.g. Caenorhabditis elegans and Drosophila melanogaster) to mammals. We particularly discuss the mammalian LRRK2 homologue, LRRK1, and those species where there is only a single LRRK homologue, discussing examples where each of the LRRK family of proteins has distinct properties as well as those cases where there appear to be functional redundancy. We conclude that uncovering the function of LRRK2 orthologues will help to elucidate the key properties of human LRRK2 as well as to improve understanding of the suitability of different animal models for investigation of LRRK2-related PD.

摘要

自富亮氨酸重复激酶2(LRRK2)被确定为晚发性常染色体显性帕金森病的致病基因以来,大量工作致力于了解LRRK2蛋白是否可能成为帕金森病(PD)的可药物作用靶点。作为这项工作的一部分,已开发出动物模型来探索LRRK2的正常功能和病理生理作用。然而,LRRK2是一个更广泛的蛋白质家族的成员,其在不同生物体中的功能仍知之甚少。在这篇综述中,我们比较了从无脊椎动物(如秀丽隐杆线虫和黑腹果蝇)到哺乳动物等不同物种的LRRK2同源物和直系同源物的生化特性信息。我们特别讨论了哺乳动物LRRK2同源物LRRK1,以及那些只有单一LRRK同源物的物种,探讨了LRRK蛋白家族中每个成员具有不同特性的例子以及那些似乎存在功能冗余的情况。我们得出结论,揭示LRRK2直系同源物的功能将有助于阐明人类LRRK2的关键特性,以及增进对不同动物模型用于研究LRRK2相关帕金森病适用性的理解。

相似文献

1
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.人类帕金森病基因LRRK2的直系同源基因在不同物种中的功能:对临床前研究中疾病建模的启示
Biochem J. 2016 Feb 1;473(3):221-32. doi: 10.1042/BJ20150985.
2
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.LRRK2 激酶抑制剂可减轻秀丽隐杆线虫和果蝇帕金森病模型中的神经退行性变和帕金森样表型。
Hum Mol Genet. 2011 Oct 15;20(20):3933-42. doi: 10.1093/hmg/ddr312. Epub 2011 Jul 18.
3
Contribution of GTPase activity to LRRK2-associated Parkinson disease.GTP酶活性对LRRK2相关帕金森病的作用
Small GTPases. 2013 Jul-Sep;4(3):164-70. doi: 10.4161/sgtp.25130. Epub 2013 Jun 10.
4
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease.富含亮氨酸重复激酶 2(LRRK2)作为帕金森病的潜在治疗靶点。
Trends Pharmacol Sci. 2012 Jul;33(7):365-73. doi: 10.1016/j.tips.2012.04.001. Epub 2012 May 9.
5
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.LRRK2 介导的帕金森病线虫模型中多巴胺能神经元的神经退行性变和功能障碍。
Neurobiol Dis. 2010 Oct;40(1):73-81. doi: 10.1016/j.nbd.2010.04.002. Epub 2010 Apr 9.
6
Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease.LRRK2 的生化和分子特征及其在帕金森病中的病理生理作用。
BMB Rep. 2010 Apr;43(4):233-44. doi: 10.5483/bmbrep.2010.43.4.233.
7
LRRK2 in Parkinson's disease: protein domains and functional insights.帕金森病中的LRRK2:蛋白质结构域与功能见解
Trends Neurosci. 2006 May;29(5):286-93. doi: 10.1016/j.tins.2006.03.006. Epub 2006 Apr 17.
8
Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.腺病毒介导的 G2019S LRRK2 的表达以激酶依赖的方式在帕金森病大鼠模型中诱导纹状体病理学。
Neurobiol Dis. 2015 May;77:49-61. doi: 10.1016/j.nbd.2015.02.019. Epub 2015 Feb 28.
9
The Parkinson disease gene LRRK2: evolutionary and structural insights.帕金森病基因LRRK2:进化与结构洞察
Mol Biol Evol. 2006 Dec;23(12):2423-33. doi: 10.1093/molbev/msl114. Epub 2006 Sep 11.
10
Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond.在秀丽隐杆线虫中对帕金森病的功能基因组学进行建模:LRRK2 及其他。
Biosci Rep. 2021 Sep 30;41(9). doi: 10.1042/BSR20203672.

引用本文的文献

1
LRRK2 Kinase Inhibitor PF-06447475 Protects Drosophila melanogaster against Paraquat-Induced Locomotor Impairment, Life Span Reduction, and Oxidative Stress.LRRK2激酶抑制剂PF-06447475可保护黑腹果蝇免受百草枯诱导的运动功能障碍、寿命缩短和氧化应激的影响。
Neurochem Res. 2024 Sep;49(9):2440-2452. doi: 10.1007/s11064-024-04141-9. Epub 2024 Jun 7.
2
Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson's disease.性别依赖性的前驱性肠道炎症与 LRRK2 G2019S 在小鼠中的相互作用促进了帕金森病的内表型。
Commun Biol. 2024 May 15;7(1):570. doi: 10.1038/s42003-024-06256-9.
3
Functions of the RIP kinase family members in the skin.RIP 激酶家族成员在皮肤中的功能。
Cell Mol Life Sci. 2023 Sep 9;80(10):285. doi: 10.1007/s00018-023-04917-2.
4
Genome-wide DNA methylation analysis in schizophrenia with tardive dyskinesia: a preliminary study.精神分裂症伴迟发性运动障碍的全基因组 DNA 甲基化分析:一项初步研究。
Genes Genomics. 2023 Oct;45(10):1317-1328. doi: 10.1007/s13258-023-01414-5. Epub 2023 Jul 6.
5
Allele-dependent interaction of LRRK2 and NOD2 in leprosy.LRRK2 与 NOD2 等位基因依赖相互作用与麻风病有关。
PLoS Pathog. 2023 Mar 27;19(3):e1011260. doi: 10.1371/journal.ppat.1011260. eCollection 2023 Mar.
6
Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects.长期抑制突变型LRRK2的高激酶活性可降低小鼠脑内α-突触核蛋白寡聚体水平,且无不良影响。
NPJ Parkinsons Dis. 2022 Sep 10;8(1):115. doi: 10.1038/s41531-022-00386-9.
7
Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade.过去十年中用于帕金森病的 LRRK2 抑制剂的结构见解和研发进展。
Genes (Basel). 2022 Aug 11;13(8):1426. doi: 10.3390/genes13081426.
8
Maintenance of mitochondrial integrity in midbrain dopaminergic neurons governed by a conserved developmental transcription factor.保守发育转录因子调控中脑多巴胺能神经元中线粒体完整性的维持。
Nat Commun. 2022 Mar 17;13(1):1426. doi: 10.1038/s41467-022-29075-0.
9
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease.LRRK2 突变敲入鼠模型:帕金森病的治疗相关性。
Transl Neurodegener. 2022 Feb 14;11(1):10. doi: 10.1186/s40035-022-00285-2.
10
Modeling Parkinson's Disease: Not Only Rodents?帕金森病建模:不仅仅是啮齿动物?
Front Aging Neurosci. 2021 Aug 6;13:695718. doi: 10.3389/fnagi.2021.695718. eCollection 2021.

本文引用的文献

1
High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes.高通量筛选小鼠基因敲除品系鉴定出已建立和新的骨骼表型。
Bone Res. 2014 Oct 28;2:14034. doi: 10.1038/boneres.2014.34. eCollection 2014.
2
Genes associated with Parkinson's disease: regulation of autophagy and beyond.与帕金森病相关的基因:自噬及其他方面的调控
J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):91-107. doi: 10.1111/jnc.13266. Epub 2015 Sep 3.
3
PLK1-dependent activation of LRRK1 regulates spindle orientation by phosphorylating CDK5RAP2.PLK1 依赖性激活 LRRK1 通过磷酸化 CDK5RAP2 调节纺锤体取向。
Nat Cell Biol. 2015 Aug;17(8):1024-35. doi: 10.1038/ncb3204. Epub 2015 Jul 20.
4
Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.帕金森症的发病途径再探讨:帕金森病遗传学中的共同病理生物学机制
Hum Mol Genet. 2015 Oct 15;24(R1):R32-44. doi: 10.1093/hmg/ddv236. Epub 2015 Jun 22.
5
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration.富含亮氨酸重复激酶2(LRRK2)的药理抑制作用可减轻α-突触核蛋白基因诱导的神经退行性变。
J Biol Chem. 2015 Aug 7;290(32):19433-44. doi: 10.1074/jbc.M115.660001. Epub 2015 Jun 15.
6
Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.富含亮氨酸重复激酶2(Lrrk2)缺乏可减轻实验性自身免疫性葡萄膜炎(EAU)的发展及适应性免疫反应。
PLoS One. 2015 Jun 11;10(6):e0128906. doi: 10.1371/journal.pone.0128906. eCollection 2015.
7
LRRK2 Pathways Leading to Neurodegeneration.导致神经退行性变的LRRK2信号通路。
Curr Neurol Neurosci Rep. 2015 Jul;15(7):42. doi: 10.1007/s11910-015-0564-y.
8
Mitochondrial degradation and energy metabolism.线粒体降解与能量代谢。
Biochim Biophys Acta. 2015 Oct;1853(10 Pt B):2812-21. doi: 10.1016/j.bbamcr.2015.05.010. Epub 2015 May 12.
9
Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury.富含亮氨酸重复序列激酶2缺乏对横纹肌溶解诱导的肾损伤具有保护作用。
Hum Mol Genet. 2015 Jul 15;24(14):4078-93. doi: 10.1093/hmg/ddv147. Epub 2015 Apr 22.
10
A novel GTP-binding inhibitor, FX2149, attenuates LRRK2 toxicity in Parkinson's disease models.一种新型的GTP结合抑制剂FX2149可减轻帕金森病模型中LRRK2的毒性。
PLoS One. 2015 Mar 27;10(3):e0122461. doi: 10.1371/journal.pone.0122461. eCollection 2015.